Search results
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time...
Motley Fool via Yahoo Finance· 1 hour agoShares of Structure Therapeutics (NASDAQ: GPCR) shot up more than 50% during the first week of June....
Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Anish Patel Sells 1,133 Shares
ETF DAILY NEWS· 5 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 1,133 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold ...
Wolfe Research bullish on Akero stock, cites NASH treatment potential By Investing.com
Investing.com· 44 minutes agoOn Tuesday, Wolfe Research initiated coverage on Akero Therapeutics (NASDAQ: NASDAQ:AKRO) stock with...
Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Target Price at $64.86
ETF DAILY NEWS· 8 hours agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the ...
Enliven Therapeutics COO sells over $22k in company stock By Investing.com
Investing.com· 12 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN) has reported a recent transaction involving its Chief...
Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 8 hours agoFate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has earned a consensus recommendation of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat ...
Rapport Therapeutics director buys $9.5 million in company stock By Investing.com
Investing.com· 11 hours agoDirector of Rapport Therapeutics, Inc. (NASDAQ:RAPP), James Healy, has recently made a substantial...
With 43% stake, Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) seems to have captured institutional...
Simply Wall St. via Yahoo Finance· 17 hours agoKey Insights Significantly high institutional ownership implies Y-mAbs Therapeutics' stock price is...
StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Sell
ETF DAILY NEWS· 4 days agoProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was downgraded by investment analysts at...
GSK acquires Elsie to unlock oligonucleotide therapeutics
Pharmaceutical Technology via Yahoo Finance· 4 days agoGSK has acquired Elsie Biotechnologies for $50m to unlock the potential of oligonucleotide ...